Skip Navigation LinksHome > April 2013 - Volume 17 - Issue > Contributor Index

April 2013 - Volume 17 - Issue - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 1 Next
Author Name Article
Castle, Philip E. PhD, MPH

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Cheung, Li C. MS

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Einstein, Mark H. MD

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Purchase Access
Erratum
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Fetterman, Barbara SCT (ASCP)

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions
for the 2012 ASCCP Consensus Guidelines Conference

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Purchase Access
Erratum
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Gage, Julia C. PhD, MPH

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Huh, Warner K. MD

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Purchase Access
Erratum
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Katki, Hormuzd A. PhD

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Purchase Access
Erratum
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Kinney, Walter K. MD

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Purchase Access
Erratum
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Lawson, Herschel W. MD

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Purchase Access
Erratum
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Lorey, Thomas MD

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Massad, L. Stewart MD

2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Purchase Access
Erratum
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Poitras, Nancy E. PMP

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of CIN 3+ to Guide the Management of Women Aged 21 to 24 Years

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Follow-up Testing After Colposcopy: Five-Year Risk of CIN 2+ After a Colposcopic Diagnosis of CIN 1 or Less

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS: Performance of HPV and Pap Cotesting in Posttreatment Management

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions
Raine-Bennett, Tina MD, MPH

Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV Testing of ASC-US Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among Women With HPV-Positive and HPV-Negative High-Grade Pap Results

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions

Five-Year Risks of CIN 3+ and Cervical Cancer Among WomenWho Test Pap-Negative But Are HPV-Positive

Purchase Access
In Brief
Abstract
PDF
+ Favorites
Request Permissions